Consistent with this, administration of staurosporine-based PKC inhibitors such as Ruboxistaurin or CGP41251 is reno-protective in rodent models of T1D (STZ) and/or T2D (db/db model)16,26,29. Here, PRRT2 is linked to type 2 diabetes mellitus.